FDA’s shortage list today
Straight from FDA’s drug shortage database, last updated by FDA in October 2026.
- semaglutide: being discontinued (Rybelsus).
- tirzepatide: not on the list.
- liraglutide: in shortage (Liraglutide, Saxenda, Victoza); being discontinued (Liraglutide, Saxenda).
FDA drug shortage database · read through openFDA · discontinuation is a maker’s decision, not a shortage
In the regulator’s own words
"FDA has determined the shortage of semaglutide injection products, a glucagon-like peptide 1 (GLP-1) medication, is resolved."
"Today, FDA has issued a new decision determining the tirzepatide injection shortage is resolved."
This page reports what the regulator has published, in its words. It is not legal or medical advice.